Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Healthpoint launches Oasis biomaterial for burns:

This article was originally published in Clinica

Executive Summary

Pharma/device company Healthpoint (Fort Worth, Texas) has launched a new naturally derived wound matrix, Oasis, for the treatment of second degree and superficial burns. The product is made from an extracellular matrix created from the submucosal layer of porcine small intestine. Healthpoint already markets a range of Oasis products for other indications, including skin loss injuries arising from surgical and trauma wounds, pressure, venous and chronic vascular and diabetic ulcers and autograft donor sites.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061850

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel